Microneedle Patch Delivering Multifunctional Melanin-like Nanoparticles for Vitiligo Remission and Repigmentation

Area of Science:

• Biomaterials Science
• Dermatology
• Nanotechnology

Background:

• Vitiligo is an autoimmune skin condition causing melanocyte destruction and depigmentation.
• Current treatments for vitiligo have limited efficacy, especially in difficult-to-treat areas.
• Melanin-like nanoparticles offer potential as therapeutic agents due to their antioxidative and immunomodulatory properties.

Purpose of the Study:

• To compare various melanin-like nanoparticles for their physical characteristics and redox activities.
• To develop a novel transdermal delivery system for melanin-like nanoparticles using dissolvable microneedle patches.
• To evaluate the efficacy of polydopamine-polyethylene glycol nanoparticles delivered via microneedles in a vitiligo mouse model.

Main Methods:

• Characterization and redox activity assessment of different melanin-like nanoparticles.
• Formulation of polyethylene glycol-modified polydopamine nanoparticles (PDA@PEG NPs) into dissolvable microneedle (MN) patches.
• In vivo evaluation of PDA@PEG/MN patches in a vitiligo mouse model, assessing repigmentation, oxidative stress, and immune cell infiltration.

Main Results:

• PDA@PEG NPs demonstrated suitable physical characteristics and redox activity for therapeutic application.
• Transdermal delivery of PDA@PEG NPs via MN patches effectively delivered nanoparticles into the superficial dermis.
• PDA@PEG NPs promoted repigmentation by providing a concealing effect and reducing oxidative stress and CD8+ T cell infiltration through Nrf2/HO-1 pathway activation.

Conclusions:

• PDA@PEG/MN patches represent a promising minimally invasive platform for vitiligo treatment.
• The nanoparticles offer a dual therapeutic approach: camouflage and active repigmentation.
• Activation of the Nrf2/HO-1 pathway is a key mechanism underlying the therapeutic effects of PDA@PEG NPs in vitiligo.